SEARCH

SEARCH BY CITATION

References

  • 1
    Gladman D, Mease P, Krueger G et al . Outcome measures in psoriatic arthritis. J Rheumatol 2007; 34: 11591166.
  • 2
    Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol 2008; 35: 13541358.
  • 3
    Espinoza LR, Cuéllar ML, Silveira LH. Psoriatic arthritis. Curr Opin Rheumatol 1992; 4: 470478.
  • 4
    Golfieri R, Giampalma E, Tosti A, Calculli L, Berardi R, Gavelli G. Psoriasis arthropathica. A review of the literature, general considerations and the authors’ personal experience.] Radiol Med 1992; 84: 228235 (in Italian).
  • 5
    Gisondi P, Girolomoni G, Sampogna F, Tabolli S, Abeni D. Prevalence of psoriatic arthritis and joint complaints in a large population of Italian patients hospitalised for psoriasis. Eur J Dermatol 2005; 15: 279283.
  • 6
    Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53: 573.
  • 7
    Ackermann C, Kavanaugh A. Economic burden of psoriatic arthritis. Pharmacoeconomics 2008; 26: 121129.
  • 8
    Taylor WJ. Epidemiology of psoriatic arthritis. Curr Opin Rheumatol 2002; 14: 98103.
  • 9
    Helliwell PS, Taylor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 2005; 64 (Suppl. 2): ii38.
  • 10
    Gladman DD. Psoriatic arthritis. Baillieres Clin Rheumatol 1995; 9: 319329.
  • 11
    Vasey F, Espinoza LR. Psoriatic arthropathy. In: CalinA, eds. Spondylarthropathies. Grune & Stratton, Orlando, FL, 1984: 151185.
  • 12
    Dougados M, Van Der Linden S, Juhlin R et al . The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 12181227.
  • 13
    Bennett RM. Psoriatic arthritis. In: McCartyDJ, ed. Arthritis and Related Conditions: A Textbook of Rheumatology. Lea & Febiger, Philadelphia,1979: 645.
  • 14
    Chandran V, Schentag CT, Gladman DD. Are the CASPAR Criteria for psoriatic arthritis accurate when applied to patients attending a family practice clinic? Arthritis Rheum 2006; 54: 4091.
  • 15
    Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973; 3: 5578.
  • 16
    Brockbank J, Stein M, Schentang C, Gladman DD. Dactylitis in psoriatic arthritis: a marker for disease severity? Ann Rheum Dis 2005; 64: 188190.
  • 17
    Vyse TJ, Todd JA. Genetic analysis of autoimmune disease. Cell 1996; 85: 311318.
  • 18
    Kavanaugh A, Ritchlin C, Boehncke WH. Quality indicators in psoriatic arthritis. Clin Exp Rheumatol 2007; 25 (6 Suppl. 47): 98101.
  • 19
    Gladman DD, Mease PJ, Healy P et al . Outcome measures in psoriatic arthritis. J Rheumatol 2007; 34: 11591166.
  • 20
    Gladman DD, Mease PJ, Krueger G et al . Outcome measures in psoriatic arthritis. J Rheumatol 2005; 32: 22622269.
  • 21
    Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137: 280284.
  • 22
    Dubertret L, Mrowietz U, Ranki A et al . European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006; 155: 729736.
  • 23
    Berger K, Ehlken B, Kugland B, Augustin M. Cost-of-illness in patients with moderate and severe chronic psoriasis vulgaris in Germany. J Dtsch Dermatol Ges 2005; 3: 511518.
  • 24
    Sohn S, Schoeffski O, Prinz J, Reich K, Schubert E, Waldorf K, Augustin M. Cost of moderate to severe plaque psoriasis in germany: a multicenter cost-of-illness study. Dermatology 2006; 212: 137144.